Entrada Therapeutics, Inc.

Historical 13F Holders

Symbol
TRDA
CUSIP
29384C108
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 29384C108 since 12/18/2024, largest first.

Filer % of Class Filed
5AM Ventures V, L.P. 13D/A
10.8% 11/18/2025
Event 11/14/2025
MPM BioVentures 2014, L.P. 13D/A
9.9% 9/10/2026
Event 9/8/2026
Roche Finance Ltd 13G/A
6.9% 2/14/2025
Event 12/31/2024
BlackRock, Inc. 13G 5.3% 2/4/2025
Event 12/31/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Janus Henderson Group PLC 13G/A 4.0% 8/14/2025
Event 6/30/2025
TCG Crossover GP I, LLC 13G/A
2.7% 8/14/2026
Event 6/30/2026
Price T Rowe Associates Inc /MD/ 13G/A 0.9% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 133 30.9 M $196M
2026 Q2 128 29.1 M $214M
2026 Q1 119 25.5 M $321M
2025 Q4 113 24.4 M $251M
2025 Q3 116 28.5 M $169M
2025 Q2 108 29.6 M $199M
2025 Q1 111 30.2 M $275M
2024 Q4 103 30.6 M $530M
2024 Q3 99 30.1 M $481M
2024 Q2 85 29.7 M $423M
2024 Q1 78 26.0 M $369M
2023 Q4 63 26.3 M $397M
2023 Q3 56 26.0 M $411M
2023 Q2 57 25.8 M $390M
2023 Q1 54 24.9 M $361M
2022 Q4 48 24.7 M $334M
2022 Q3 34 24.5 M $386M
2022 Q2 39 24.8 M $302M
2022 Q1 49 25.9 M $243M
2021 Q4 47 25.4 M $434M